First report of Fasciola hepatica seroprevalence and risk factors in European bison (Bison bonasus)
04 abr 2025
Acerca de este artículo
Publicado en línea: 04 abr 2025
Páginas: 227 - 232
Recibido: 07 oct 2024
Aceptado: 24 mar 2025
DOI: https://doi.org/10.2478/jvetres-2025-0020
Palabras clave
© 2025 Anna Didkowska et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Fig. 1.

Fig. 2.

Effect of sex and site on Fasciola hepatica seropositivity in European bison_ The age variable was excluded in the model selection procedure
B | SE | Lower CI | Upper CI | Wald chi2 | P-value | |
---|---|---|---|---|---|---|
Intercept | –2.392 | 0.3611 | –3.099 | –1.684 | 43.872 | <0.001 |
Female | 1.090 | 0.3087 | 0.485 | 1.695 | 12.462 | <0.001 |
Male | 0 |
|||||
Lowland location | 1.544 | 0.3433 | 0.872 | 2.217 | 20.243 | <0.001 |
Mountain location | 0 |